BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572 AND Treatment
7 results:

  • 1. Prognostic and predictive value of super-enhancer-derived signatures for survival and lung metastasis in osteosarcoma.
    Huang G; Zhang X; Xu Y; Chen S; Cao Q; Liu W; Fu Y; Jia Q; Shen J; Yin J; Zhang J
    J Transl Med; 2024 Jan; 22(1):88. PubMed ID: 38254188
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Understanding the Critical Role of Glycolysis-Related lncRNAs in lung Adenocarcinoma Based on Three Molecular Subtypes.
    Cao P; Zhao B; Xiao Y; Hu S; Kong K; Han P; Yue J; Deng Y; Zhao Z; Wu D; Zhang L; Li F
    Biomed Res Int; 2022; 2022():7587398. PubMed ID: 35178454
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Circle RNA foxp1 promotes cell proliferation in lung cancer by regulating miR-185-5p/Wnt1 signaling pathway.
    Li O; Kang J; Zhang JJ; Wang J; Hu LW; Li L; Sun YY; Bai Y; Wei QQ; Yan YP; Yi X
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6767-6778. PubMed ID: 32633368
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
    Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
    Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes.
    Cheng F; Zhao J; Fooksa M; Zhao Z
    J Am Med Inform Assoc; 2016 Jul; 23(4):681-91. PubMed ID: 27026610
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Uncovering Direct Targets of MiR-19a Involved in lung cancer Progression.
    Yamamoto K; Ito S; Hanafusa H; Shimizu K; Ouchida M
    PLoS One; 2015; 10(9):e0137887. PubMed ID: 26367773
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
    Nasser MW; Datta J; Nuovo G; Kutay H; Motiwala T; Majumder S; Wang B; Suster S; Jacob ST; Ghoshal K
    J Biol Chem; 2008 Nov; 283(48):33394-405. PubMed ID: 18818206
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.